Global Hydroxychloroquine (Plaquenil) Market Research Report 2020

Hydroxychloroquine is a racemic mixture consisting of an R and S enantiomer.2 Hydroxychloroquine is an aminoquinoline like chloroquine. It is a commonly prescribed medication in the treatment of uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, and systemic lupus erythematosus. Hydroxychloroquine is also used for the prophylaxis of malaria in regions where chloroquine resistance is unlikely. It was developed during World War II as a derivative of quinacrine with less severe side effects.6 Chloroquine and hydroxychloroquine are both being investigated for the treatment of SARS-CoV-2.7It is taken by mouth.[2] It is also being used as an experimental treatment for coronavirus disease 2019 (COVID-19).

The global Hydroxychloroquine (Plaquenil) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
This report focuses on Hydroxychloroquine (Plaquenil) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hydroxychloroquine (Plaquenil) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Hydroxychloroquine (Plaquenil) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Hydroxychloroquine (Plaquenil) market is segmented into
100mg
200mg
Other

Segment by Application
Lupus Erythematosus
Rheumatoid Arthritis
COVID-19
Others

Global Hydroxychloroquine (Plaquenil) Market: Regional Analysis
The Hydroxychloroquine (Plaquenil) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Hydroxychloroquine (Plaquenil) market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Global Hydroxychloroquine (Plaquenil) Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Hydroxychloroquine (Plaquenil) market include:
Sanofi
Actavis (TEVA )
Mylan
Novartis
Covis Pharmaceutical
Cardinal Health
Apotex Corporation
Hikma Pharmaceuticals
Aphena Pharma
Concordia Healthcare
AvKARE (Amneal Pharmaceuticals)
Ipca Laboratories
Shanghai Pharmaceuticals Holding
Taj Pharmaceuticals
Cinkate Corporation
Cadila Healthcare
Sun Pharma
Zydus Cadila
Advanz Pharma
Bristol Laboratories
Hanlim Pharmaceutical
Kyung Poong